112 related articles for article (PubMed ID: 31401605)
1. Effectiveness of omega-3 fatty acid administration on completion rate of adjuvant chemotherapy for biliary tract cancer: study protocol for a single-centre, open-label, single-arm, historically controlled study.
Ueno K; Ajiki T; Tsugawa D; Akita M; Hashimoto Y; Awazu M; Mukubo H; Komatsu S; Kuramitsu K; Terai S; Tanaka M; Toyama H; Kido M; Fukumoto T
BMJ Open; 2019 Aug; 9(8):e029915. PubMed ID: 31401605
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of fluoropyrimidine-based adjuvant chemotherapy on biliary tract cancer after R0 resection.
Kim YS; Jeong CY; Song HN; Kim TH; Kim HJ; Lee YJ; Hong SC
Chin J Cancer; 2017 Jan; 36(1):9. PubMed ID: 28086990
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of oral administration of cystine and theanine in patients with colorectal cancer undergoing capecitabine-based adjuvant chemotherapy after surgery: study protocol for a multi-institutional, randomised, double-blinded, placebo-controlled, phase II trial.
Hamaguchi R; Tsuchiya T; Miyata G; Sato T; Takahashi K; Ariyoshi K; Oyamada S; Iwase S
BMJ Open; 2018 Jul; 8(7):e021442. PubMed ID: 30030317
[TBL] [Abstract][Full Text] [Related]
4. Phase 2 Trial of Adjuvant Chemotherapy With S - 1 for Node-Positive Biliary Tract Cancer (N-SOG 09).
Seita K; Ebata T; Mizuno T; Maeda A; Yamaguchi R; Kurumiya Y; Sakamoto E; Hiramatsu K; Ando M; Nagino M
Ann Surg Oncol; 2020 Jul; 27(7):2348-2356. PubMed ID: 32180066
[TBL] [Abstract][Full Text] [Related]
5. Activity and safety of RAD001 (everolimus) in patients affected by biliary tract cancer progressing after prior chemotherapy: a phase II ITMO study.
Buzzoni R; Pusceddu S; Bajetta E; De Braud F; Platania M; Iannacone C; Cantore M; Mambrini A; Bertolini A; Alabiso O; Ciarlo A; Turco C; Mazzaferro V
Ann Oncol; 2014 Aug; 25(8):1597-603. PubMed ID: 24827133
[TBL] [Abstract][Full Text] [Related]
6. [Current status of adjuvant therapy for biliary tract cancer].
Kato A; Miyazaki M
Nihon Geka Gakkai Zasshi; 2014 Jul; 115(4):206-11. PubMed ID: 25154240
[TBL] [Abstract][Full Text] [Related]
7. The efficiency and regimen choice of adjuvant chemotherapy in biliary tract cancer: A STROBE-compliant retrospective cohort study.
Yin L; Xu Q; Li J; Wei Q; Ying J
Medicine (Baltimore); 2018 Dec; 97(50):e13570. PubMed ID: 30558021
[TBL] [Abstract][Full Text] [Related]
8. Effects of vitamin D and omega-3 fatty acids co-supplementation on inflammatory biomarkers, tumor marker CEA, and nutritional status in patients with colorectal cancer: a study protocol for a double blind randomized controlled trial.
Haidari F; Abiri B; Iravani M; Razavi SM; Sarbakhsh P; Ahmadi-Angali K; Vafa M
Trials; 2019 Dec; 20(1):682. PubMed ID: 31815661
[TBL] [Abstract][Full Text] [Related]
9. Effects of an enteral nutrient-rich therapy with omega-3 fatty acids in patients with unresectable or recurrent biliary tract cancer or pancreatic cancer during chemotherapy: a case-control study.
Abe K; Uwagawa T; Hamura R; Shirai Y; Yasuda J; Furukawa K; Shiozaki H; Onda S; Gocho T; Ikegami T
Med Oncol; 2022 Apr; 39(5):66. PubMed ID: 35478069
[TBL] [Abstract][Full Text] [Related]
10. Pitfalls, challenges, and updates in adjuvant systemic treatment for resected biliary tract cancer.
Rizzo A; Brandi G
Expert Rev Gastroenterol Hepatol; 2021 May; 15(5):547-554. PubMed ID: 33571059
[No Abstract] [Full Text] [Related]
11. BILCAP trial and adjuvant capecitabine in resectable biliary tract cancer: reflections on a standard of care.
Rizzo A; Brandi G
Expert Rev Gastroenterol Hepatol; 2021 May; 15(5):483-485. PubMed ID: 33307876
[TBL] [Abstract][Full Text] [Related]
12. Supervised Exercise Therapy and Adjuvant Chemotherapy for Pancreatic Cancer: A Prospective, Single-Arm, Phase II Open-Label, Nonrandomized, Historically Controlled Study.
Okada KI; Kouda K; Kawai M; Hirono S; Miyazawa M; Kitahata Y; Kawanishi M; Natsume Y; Wan K; Yamaue H
J Am Coll Surg; 2022 Dec; 235(6):848-858. PubMed ID: 36102519
[TBL] [Abstract][Full Text] [Related]
13. A combination of hydroxytyrosol, omega-3 fatty acids and curcumin improves pain and inflammation among early stage breast cancer patients receiving adjuvant hormonal therapy: results of a pilot study.
Martínez N; Herrera M; Frías L; Provencio M; Pérez-Carrión R; Díaz V; Morse M; Crespo MC
Clin Transl Oncol; 2019 Apr; 21(4):489-498. PubMed ID: 30293230
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant chemotherapy versus surgery first for resectable pancreatic cancer (Norwegian Pancreatic Cancer Trial - 1 (NorPACT-1)) - study protocol for a national multicentre randomized controlled trial.
Labori KJ; Lassen K; Hoem D; Grønbech JE; Søreide JA; Mortensen K; Smaaland R; Sorbye H; Verbeke C; Dueland S
BMC Surg; 2017 Aug; 17(1):94. PubMed ID: 28841916
[TBL] [Abstract][Full Text] [Related]
15. Role of adjuvant and neoadjuvant therapy for resectable biliary tract cancer.
Nara S; Esaki M; Ban D; Takamoto T; Mizui T; Shimada K
Expert Rev Gastroenterol Hepatol; 2021 May; 15(5):537-545. PubMed ID: 33793366
[No Abstract] [Full Text] [Related]
16. Adjuvant chemotherapy in biliary tract cancer patients: A systematic review and meta-analysis of randomized controlled trials.
Caparica R; Bruzzone M; Hachem GE; Ceppi M; Lambertini M; Glasberg J; de Azambuja E; Van Laethem JL; Hendlisz A
Crit Rev Oncol Hematol; 2020 May; 149():102940. PubMed ID: 32252001
[TBL] [Abstract][Full Text] [Related]
17. A randomized Phase III trial of adjuvant S-1 therapy vs. observation alone in resected biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1202, ASCOT).
Nakachi K; Konishi M; Ikeda M; Mizusawa J; Eba J; Okusaka T; Ishii H; Fukuda H; Furuse J;
Jpn J Clin Oncol; 2018 Apr; 48(4):392-395. PubMed ID: 29462482
[TBL] [Abstract][Full Text] [Related]
18. Regional chemotherapy in biliary tract cancers--a single institution experience.
Melichar B; Cerman J; Dvorák J; Jandík P; Mergancová J; Melicharová K; Tousková M; Krajina A; Voboril Z
Hepatogastroenterology; 2002; 49(46):900-6. PubMed ID: 12143237
[TBL] [Abstract][Full Text] [Related]
19. Multifaceted intervention to enhance cognition in older people at risk of cognitive decline: study protocol for the Protein Omega-3 and Vitamin D Exercise Research (PONDER) study.
Macpherson H; Brownell S; Duckham RL; Meyer B; Mirzaee S; Daly RM
BMJ Open; 2019 May; 9(5):e024145. PubMed ID: 31072850
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant treatment in biliary tract cancer: to treat or not to treat?
Cereda S; Belli C; Reni M
World J Gastroenterol; 2012 Jun; 18(21):2591-6. PubMed ID: 22690066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
